Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis

被引:118
作者
Pardo, J
Basque, A
Brehm, R
Wallich, R
Naval, J
Müllbacher, A
Anel, A
Simon, MM [1 ]
机构
[1] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany
[2] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain
[3] Univ Klinikum Heidelberg, Inst Immunol, D-69120 Heidelberg, Germany
[4] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia
关键词
D O I
10.1083/jcb.200406115
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Purified cytolytic T lymphocyte (CTL) proteases granzyme (gzm)A and gzmB with sublytic dose of perforin (perf) initiate distinct proapoptotic pathways. Their physiological relevance in CTL-mediated target cell apoptosis is elusive. Using ex vivo virus-immune CD8(+) T cells from mice deficient in perf, gzmA and/or gzmB, and the Fas-resistant EL4.F15 tumor target cell, we show that (a) CTL from gzmA(-/-) or gzmB(-/-) mice similarly induced early proapoptotic features, such as phosphatidyl serine (PS) exposure on plasma membrane, DeltaPsi(m) loss, and reactive oxygen radical generation, though with distinct kinetics; (b) CTL from gzmA(-/-) but not from gzmB(-/-) mice activate caspase 3 and 9; (c) PS exposure induced by CTL from gzmA(-/-) or gzmB(-/-) mice is prevented, respectively, by caspase inhibitors or by reactive oxygen scavengers without interfering with target cell death; and (d) all gzm-induced apoptotic features analyzed depend critically on perf. Thus, perf is the principal regulator in CTL-mediated and gzm-facilitated intracellular processes. The ability of gzmA and gzmB to induce multiple independent cell death pathways may be the hosts response to circumvent evasion strategies of pathogens and tumors.
引用
收藏
页码:457 / 468
页数:12
相关论文
共 66 条
[1]   Granzyme B induces BID-mediated cytochrome c release and mitochondrial permeability transition [J].
Alimonti, JB ;
Shi, LF ;
Baijal, PK ;
Greenberg, AH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) :6974-6982
[2]   Detection of caspase activation in situ by fluorochrome-labeled caspase inhibitors [J].
Amstad, PA ;
Yu, G ;
Johnson, GL ;
Lee, BW ;
Dhawan, S ;
Phelps, DJ .
BIOTECHNIQUES, 2001, 31 (03) :608-+
[3]   Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection [J].
Balkow, S ;
Kersten, A ;
Tran, TTT ;
Stehle, T ;
Grosse, P ;
Museteanu, C ;
Utermöhlen, O ;
Pircher, H ;
von Weizsäcker, F ;
Wallich, R ;
Müllbacher, A ;
Simon, MM .
JOURNAL OF VIROLOGY, 2001, 75 (18) :8781-8791
[4]   Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving bid [J].
Barry, M ;
Heibein, JA ;
Pinkoski, MJ ;
Lee, SF ;
Moyer, RW ;
Green, DR ;
Bleackley, RC .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (11) :3781-3794
[5]   To kill or be killed: viral evasion of apoptosis [J].
Benedict, CA ;
Norris, PS ;
Ware, CF .
NATURE IMMUNOLOGY, 2002, 3 (11) :1013-1018
[6]   Interaction of human apurinic endonuclease and DNA polymerase beta in the base excision repair pathway [J].
Bennett, RAO ;
Wilson, DM ;
Wong, D ;
Demple, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) :7166-7169
[7]   Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation [J].
Beresford, PJ ;
Xia, ZN ;
Greenberg, AH ;
Lieberman, J .
IMMUNITY, 1999, 10 (05) :585-594
[8]   CYTOKINES IN THE GENERATION OF IMMUNE-RESPONSES TO, AND RESOLUTION OF, VIRUS-INFECTION [J].
BIRON, CA .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (04) :530-538
[9]   A unified model for apical caspase activation [J].
Boatright, KM ;
Renatus, M ;
Scott, FL ;
Sperandio, S ;
Shin, H ;
Pedersen, IM ;
Ricci, JE ;
Edris, WA ;
Sutherlin, DP ;
Green, DR ;
Salvesen, GS .
MOLECULAR CELL, 2003, 11 (02) :529-541
[10]   Cellular responses to interferon-gamma [J].
Boehm, U ;
Klamp, T ;
Groot, M ;
Howard, JC .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :749-795